Dual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background

Similar documents
CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS

In-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and nm wavelengths.

FEB-2015 ISSUE. Dr. David Pudukadan

SPECIAL TOPIC. AboutSkin Dermatology & DermSurgery, Greenwood Village, CO b. The Aesthetic Clinique, Destin, FL c

Daryl Mossburg, BSN RN Clinical Specialist Sciton, Inc.

In Vivo Histological Evaluation of a Novel YSGG Ablative Fractional Device for Cutaneous Remodeling

Clinical Efficacy and Statistical Evaluation of INTRAcel Treatment

NONABLATIVE RESURFACING

ProFractional. ProFractional Therapy. Tunable Fractional Solution. Advanced Fractional Aesthetic Laser Surgery

Non-Ablative Rejuvenation

Multi-Application Platform. Summary of Peer-reviewed Articles for Various Clinical Indications April 2016

Hands-on: Lasers. NonAblative Rejuvenation

Information and Consent For Intracel

NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD

PHYSICIANS GUIDE. Understanding Fraxel TM Laser Treatment

Casnigo, April, the 21 st, Operative Protocols for PRISMA Nd: YAG laser 1440

High Power CO2 Laser + Micro-needle Fractional RF

Arisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego

Review of Fractional Photothermolysis: Treatment Indications and Efficacy

Laser Skin Rejuvenation

XF Microlens Optic and XD Microlens Compression Optic for Non-Ablative Fractional Skin Treatment with the Palomar Icon System

NEW IN-DEMAND AESTHETICS IN ONE PLATFORM TECH BREAKTHROUGH PLUS

LASER TREATMENT PEARLS FOR PHOTO-REJUVENATION

Ablative Skin Resurfacing With a Novel Microablative CO 2 Laser

NEOGENEVO ENERGIST NITROGEN PLASMA SYSTEM SKIN RESURFACING SKIN REJUVENATION SKIN TIGHTENING SKIN REGENERATION SEVERE AND FINE WRINKLE REDUCTION

Treatment of aging skin using the SharpLight Omnimax Stacked multiple modality platform

Superior RF Multi-Treatment Platform

Laser Skin Rejuvenation

Superior RF Multi-Treatment Platform

Presentation Product & clinics

A novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: A pilot study

Light EVO. Taking care of people, our masterpieces. Multiple Wavelengths for the Highest Challenges in Laser Applications.

Clinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System

Photodamaged skin occurs as a result of its

Aesthetic Laser Industry Why the excitement?

Fractional treatment of aging skin with Tixel, a clinical and histological evaluation

AESTHETIC DERMATOLOGY AND LASER Dra. Soledad Sáenz

Physician s Clinical Guideline

Evaluation of the wound healing response post - deep dermal heating by fractional RF: INTRACEL

CO 2 Laser Treatment Periocular Area. Prof. G.Cannarozzo

Evaluation of the wound healing response post deep dermal heating by fractional RF: INTRAcel

1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study

The use of light as a medical treatment has SPECIAL TOPIC. Fractional Photothermolysis for Skin Rejuvenation.

Hybrid Energy TM Technology

Treat Your Patients Better

Citation for published version (APA): van Drooge, A. M. (2014). Improvement of disfiguring skin conditions by laser therapy

Mona SC-2 Ultra Pulse Co2 Fractional laser system. Beijing Sanhe Beauty S & T Co.,Ltd

StarLux Fractional Non-Ablative Skin Resurfacing

Clinical experiences in Asian skin with new technology of ablative fractional Er:YAG Laser

LIGHT SERIES MULTIPLE WAVELENGTHS FOR THE HIGHEST CHALLENGES IN LASER APPLICATIONS

Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments

Nonablative Infrared Skin Tightening in Type IV to V Asian Skin: A Prospective Clinical Study

Treatment of periorbital wrinkles with 1,550 and 1,565 nm Er:Glass fractional photothermolysis lasers: A simultaneous split-face trial

Management of Acne Scarring

Efficacy of minimally invasive nonthermal laser-induced optical breakdown technology for skin rejuvenation

Dual modality body shaping study with RF and IR technologies utilizing SharpLight s FormaxPlus Platform.

Micro-island damage with a nonablative 1540-nm Er:Glass fractional laser device in human skin

High Intensity Focused Ultrasound Facial Skin Lifting

Diode Lasers Enable Diverse Therapeutic Applications

MCL31 Dermablate THE WORLD S MOST SUCCESSFUL ERBIUM:YAG LASER FOR AESTHETIC MEDICINE

combining Fractional RF and Superficial RF

Non-ablative Acne Scar Reduction with a Short-Pulsed 1064-nm Nd:YAG Laser a Pilot Study

NEOGEN Evo ENE RGI ST NITROGEN PLASMA SYSTEM ARTG SKIN RESURFACING SKIN REGENERATION SOFT BLEPHAROPLASTY MELASMA SKIN TIGHTENING

Treatment of aging skin using the Sharplight Omnimax multiple modality platform

Conventional ablative carbon dioxide (CO 2 ) and

Icon specifications. Handpiece compatibility

Palomar Icon 1540 Fractional Laser. Fractional Non-Ablative Skin Resurfacing

NOVEL MULTI-SOURCE PHASE-CONTROLLED RADIOFREQUENCY TECHNOLOGY FOR NON- ABLATIVE AND MICRO-ABLATIVE TREATMENT OF WRINKLES, LAX SKIN AND ACNE SCARS

ACNE IS A COMMON DISORder,

PHOTO REJUVENATION UTILIZING A KRYPTON LIGHT SOURCE:A CLINICAL AND HISTOLOGICAL STUDY

BBLs BroadBand Light. Daryl Mossburg, RN BSN Clinical Specialist Sciton, Inc. All rights reserved.

MultiPulse PRO - CO 2 Laser -

UltraPulse Encore. Bridge Therapy Fractional CO 2.

Advances in Lasers for Skin of Color

ClearSkin. Er:Glass 1540nm Laser Module. Orly Baror Gal, Eng.BioMedical. Clinical Applications Specialist

Reports on Scientific Meeting

Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars

PROVIDER ACCREDITATION

M & T srl. medical & technology

Our Approach to Non-Ablative Treatment Of Photoaging

Chapter 19: FotoFacial RF Pro Parameters

Comparison of the Effectiveness of Ablative and Non-Ablative Fractional Laser Treatments for Early Stage Thyroidectomy Scars

A G E N D A. I. Non-Invasive Body Contouring II. Benefits III. Treatment Options IV. Treatment Zones V. Q&A VI. Media VII.Results

Dual Wavelength Phototherapy System

special report special report MULTIPLE CONDITIONS EFFECTIVELY TREATED WITH THE PLASMA SKIN REGENERATION SYSTEM

Clinical Benefit of Combination Treatment with 1,550 nm Fractional Laser and a New Wavelength at 1,927 nm on Photorejuvenation in Asian Patients

Disclosures. Laser Treatment of Scars. Options for Cutaneous Scarring. Laser Treatment of Erythematous Scars. Laser Scar Revision Scar Type

Be an artist of the new

In Vivo Histological Evaluation of a Novel Ablative Fractional Resurfacing Device

Do Not Copy. Penalties Apply

Using Normal and High Pulse Coverage With Picosecond Laser Treatment of Wrinkles and Acne Scarring: Long Term Clinical Observations

Fractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses COS DERM

BISON. Accento. 755nm Long Pulsed Alexandrite Laser 1064nm Long Pulsed Nd:YAG Laser FOR EXPORT ONLY

A Novel Approach for Acne Treatment

Just the Facts Ma am

MCL 30. MCL 30 Dermablate Fractional Er:YAG (with MICROSPOT EXTENSION SET) EN 1

LASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD

A CLINICAL STUDY OF MICRODERMABRASION WITH VITAMIN C SERUM FOR FACIAL MELANOSES AND REJUVENATION Sanjana A. S 1, S. Sacchidanand 2

Microneedling for acne scars in Asian skin type: an effective low cost treatment modality

Treatment of Leg Telangiectasia (Spider Veins) with Magma Long Pulse ND - Laser 1064 nm Case Study

Transcription:

Dual wavelength (1540nm + 10600 nm) mixed technology for fractional resurfacing in skin rejuvenation Dr. Paolo Sbano, M.D. Specialist in Dermatology and Venereology Department of Dermatology of Belcolle Hospital A.S.L. Viterbo, Italy Background Despite the fact that laser resurfacing represents the most effective option in the treatment of aged skin to date, the risks and side effects connected with that have encouraged industry and clinical research to purpose alternative skin resurfacing techniques. Fractionated photothermolysis (FP) represents one of the most exciting technological discoveries in laser resurfacing of the last two decades. In 2004 Manstein and colleagues introduced FP with their original prototype device. The device emitted light in a pixilated fashion to the skin, producing an array of micro-thermal zone and creating small columns of thermal injury to the skin without ablation (non ablative FP). This concept of fractional emission of light into microscopic zones of injury contrasts with full ablative skin resurfacing, in which a confluent, uniform patch of epidermal or dermal injury is induced. The scientific concept underlying FP involves the application of microscopic beams of pixilated light, which induce small, focal zones of tissue injury. Because the pixilated zones of treatment spare surrounding normal tissue, re-epithelialization occurs at a significantly faster pace. The tissue injury created with FP stimulates the process of collagen remodeling and deposition and promotes elastic tissue formation. These molecular changes are postulated to be responsible for the clinical improvements seen with FP. With FP, laser parameters can be customized to produce differing three-dimensional columns of in- jury with varying shapes and depths. Hantash and colleagues demonstrated the first report of a prototype device of a novel ablative FP (fractionated CO2 laser) device in human skin in vivo in 2007. The results indicated a similar column of thermal coagulation as with the non-ablative FP device of Manstein and colleagues, with the critical distinction of a confluent column of ablation and thermal injury that extended from the dermis and epidermis through the stratum corneum. With ablative FP, immune-histochemical studies indicated a prolonged wound remodeling response for at least 3 months after treatment. With this prolonged stimulation of wound repair induced by ablative FP, Hantash and colleagues theorized that greater clinical improvements in skin texture and wrinkling could be achieved with ablative FP than with FP.

The uses of computer-aided scanners permits to vary the ablation/coagulation depth without varying the fluence (trough the repeated heat on the same point: staking), the space between points, the ord of emission in the square. Ablative FP have demonstrated a very low risk of side effects (post inflammatory hyperpigmentation, prolonged erythema and edema, scarring), even in dark skin phototypes, and a very shorter down time period if compared with full ablative resurfacing. Ablative FP has demonstrated useful in moderate to severe acne scarring in terms of clinical improvement and topographic mapping of decreases in individual scar volume, even non-ablative FP have been demonstrated greater results in scar remodeling if compared with ablative FP. In addition, ablative FP has shown great result in reducing skin surface and texture abnormalities, including moderate to severe rhytides and skin laxity on the face, neck, and chest. The relative limit of ablative FP is that, to obtain greater results, is necessary to use energy densities similar to the full ablative technique. The excitement of the initial reports of the efficacy of ablative FP in skin tightening, with similar results to those of traditional full ablative CO2 resurfacing, with advantages of only 7 to 14 days of downtime and less risk of permanent scarring and depigmentation have actually been resized. On the other hand, the results of non-ablative FP in aged skin cannot be compared with ablative techniques ones. Moreover, even if post-treatment associated down-time is shorter (with slight erythema and edema), more treatment sessions are needed with extended time loss for the patient and the physician too. In order to resolve these limitations of ablative/non-ablative FP a new device, combining a nonablative source (1540 nm wavelength) with an ablative one (10600 nm wavelength), both fractionated, have been proposed. The present study has the aim to investigate the efficacy, down-time period and possible side effects of a new treatment with a double wavelength (1540 nm + 10600 nm) device in photo-aged skin. Patients and methods Patients 10 Subjects, all female, mean age of 46 years (34 to 72 years) with skin phototype II-III were enrolled for the study. All subjects underwent a pre-treatment medical examination, clinical history was taken, presence of hypertrophic scars and dermatological pathologies associated with photosensitivity were investigated, risk of infection (personal history of labial herpes simplex) and any medication in place was asked. The subjects were divided into two groups on the basis of the degree of skin aging (Glogau scale): in group A were included subjects with mild-average aging (type I-II Glogau scale) and in group B with more marked aging (type III-IV Glogau scale).

Fractional Resurfacing Technique All subjects were treated with both sources (1540 nm and 10600 nm) in sequential mode in which the first impulse was of 1540 and the second pulse that of 10600. This output mode has been selected on the basis of our histologic studies in an in vivo animal model that showed this as the way that offers the maximum capacity of laser penetration into the dermis and deep and lateral coagulation with reduced ablation area. The specific characteristics of the treatment for the two groups are shown in Table 1. All subjects received a full-face fractional resurfacing, however in each patient was drawn a pretreatment map with an area of more intense treatment and areas of shade and of conjunction. The parameters that have been changed between the treatment area and the shade area were the staking and density, while the fluence were unchanged. Laser treatment parameters Group A Group B Power 1540 (W) 8 8 Pulse duration 1540 (msec) 4 6 Pause between 1540 and 10600 5 5 pulse (msec) Power 10600 (W) 10 20 Pulse duration 10600 (msec) 1 1.5 Stack 1 2 Stacking pause (msec) 2 2 Density medium medium None of the treated subjects had need of pre-treatment with anesthesia (sedation). None of the subjects in group A was treated with the aid of local or topic anesthesia. 3/5 of the subjects in group B were treated with local (regional) anesthesia in the peri-oral area. All subjects were treated with aid of cooling air system (Zimmer). Post-treatment therapy included in all subjects: doxiciclyn 100 mg/day orally for 15 days. Antiviral drugs (acyclovir 1200 mg/day orally for 7 days) were prescribed in case of herpes simplex personal history.

Results Mean down-time after treatment was 4 days in group A and 7 days in group B. Group A subjects experienced only mild to severe erythema and oedema (especially in first two days after treatment) and slight crusting. All the group A subjects obtained complete healing after 7 days. Group B subjects presented severe erythema and oedema (especially in peri-orbital area) in the first 3 days, with pinpoint crusting. All group B subjects assumed anti-inflammatory drugs in the first 3 days after treatment. At day 10 all the group B subjects had complete healing with no evidence of erythema. No side effects or complications were observed in any treated subject. All treated subjects obtained an objective improvement of their skin texture 3 months after treatment. All subjects showed satisfaction from the treatment received. We have submitted a questionnaire to the subjects dealt with a scale of evaluation of the results obtained with a value from 1 (poor performance) to 10 (excellent result). The average rating by the subjects in group A was 7 and for individuals in group B was 8.5. The different measurement is in our opinion related to the specific treatment, more incisive in subjects of group B compared to group A. The objective evaluation on the average reduction of wrinkle depth was 15% in patients of group A and 35% in patients of group B. The improvement in skin texture was 35% in group A and 55% in group B. Comment The growing demand by patients of methodologies useful to treat photo-aging that demonstrate effectiveness and at the same time not forcing long periods of abstention from social activities has led the industry of laser technologies to develop new tools and application protocols. In recent years the development of fractional technology has allowed a clear step forward in this direction, allowing savings in down-time and post-treatment risk reduction compared to the previous technique of full-ablative resurfacing. However it was noted that to obtain good results it is

necessary to push the fractional technology level in the direction of more aggressive treatments, with a surface ablation of 50-75%. This resulted in a return to long recovery time for the patient and with an increased risk of side effects. The possibility of combining an ablative fractional technology with a non-ablative one seems to offer a solution to the problem, since it allows to obtain a large coagulation effect into the medium and deep dermis with a net savings on the surface ablation. This leads to achieve the same effects in the depth of dermal remodelling with a net savings on collection times post-treatment for the patient, which are essentially related to epidermal damage. The present study shows how new technology Dual Wavelength (1540 nm + 10 600 nm) allows to obtain good results on remodelling and skin texture with a marked reduction in recovery time compared to normal techniques of ablative fractional resurfacing.